Vaccine Design

Bacterial BCG Vector Could Advance TB Vaccine

Published in TB and Outbreaks Week, May 8th, 1995

An idealized Bacillus Calmette-Gurin (BCG) vaccine for the prevention of tuberculosis (TB) would carry foreign antigens using a plasmid-based system, according to a California report.

Stanford University researchers described the development of antigen expression systems elicited by recombinant BCG vaccine strains to bacterial and HIV antigens ("Bacterial Vaccine Vectors and Bacillus Calmette-Guerin," Clinical Infectious Diseases, April 1995;20:1011-1009).

Researcher Jeffrey D. Cirillo and colleagues propose a modified recombinant BCG carrier with selection for the stable maintenance of rDNA.

Recent advances in biotechnology now...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1995-05-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry